Industry

Multiple media sources are reporting on new data from the CDC revealing a substantial increase in the suicide rate in the United States between 1999...

Researchers argue for plurality and diversity among psychotherapy approaches and question the perceived superiority of Cognitive Behavioral Therapy (CBT).

From Quartz: Despite its inaccuracy, the chemical imbalance theory of mental illness continues to persist in public consciousness. The prevalence of this myth may be...

In recent months, two teams of researchers in the UK and the US published complementary findings about the epigenetic origins of schizophrenia that have scientific communities who indulge in ‘genetic conspiracy theories’ abuzz. While these results are intriguing, and no doubt involve pathbreaking research methodologies, this line of thought represents a decontextualized understanding both of the symptoms that are typically associated with schizophrenia, and their causes.

A group of researchers in Denmark examines what existing animal studies can tell us about the sexual side-effects of SSRI antidepressants.

MIA's Gavin Crowell-Williamson interviews PharmedOut founder Dr. Adriane Fugh-Berman about Big Pharma's influence on medical education.

“This research points to the inadequacy of asking the simple question: ‘Do antidepressants work?’ Instead, the value or otherwise of antidepressants needs to be understood in the context of the diversity of experience and the particular meaning they hold in people’s lives.”

20-year follow-up study finds that after four years, patients not prescribed antipsychotics have significantly better work functioning.

The results of five large-scale clinical trials of antidepressants have never been made accessible to the public, a data set compiled by an international team of researchers shows. Their discovery highlights the incompleteness of available data on the safety and efficacy of antidepressant drugs.

Prominent researchers conduct a review of antidepressant withdrawal incidence, duration, and severity. Results lead to call for new clinical guidelines.

On Canada's popular national CBC radio program The Sunday Edition, psychiatrist Jeffrey Lieberman today described Robert Whitaker as "a menace to society."

A new special issue brings together articles exploring the harmful effects of simultaneous multiple medication use.

Researcher criticizes the many ways opposing viewpoints and dissenting voices are squashed in the field of medicine.

Researchers examined the dearth of support for Electroconvulsive therapy (ECT) for depressive symptoms in light of studies detailing the associated risks.

Patients who recover from a single episode of psychosis are often prescribed antipsychotics long-term, despite a lack of evidence for this practice

As a trauma survivor growing up in various adolescent mental health systems, I never learned any useful self-care tools or practices. I was taught that my current coping skills (self-injury, suicidal behavior, illicit drug use) were unacceptable, but not given any ideas as to what to replace them with. No one seemed to want to know much about the early childhood traumas that were driving these behaviors. Instead, I collected an assortment of diagnoses. I was told that I would be forever dependent on mediated relationships with professionals, and an ever-changing combination of pills. The message was that my troubles were chemical in nature and largely beyond my control.

Researchers examine psychiatrist-client interactions and find that clients are often left with few opportunities to make explicit requests to change their medication regimen.

Researchers take action after study exposes enduring sexual dysfunction as a potential side effect of serotonin reuptake inhibiting antidepressants, 5α-reductase inhibitors, and isotretinoin.

-A psychiatrist asserts that psychiatrists and pharmaceutical companies never promoted the idea that serotonin deficiencies could cause depression, and suggests that no one at Mad in America has evidence that they did.

A new study has found that of 10 people who were fully recovered from their first episode of schizophrenia (FES), those not taking antipsychotics did better in terms of cognitive, social, and role functioning—and reached full recovery more quickly.

A new review highlights the effects that psychiatric diagnosis has on children and adolescents’ social relationships and views of self.

Historical, current, and potential future complexities of cognitive assessment; a longstanding, controversial fixture in schools throughout the United States.

A new article documents the “flimsy evidence” behind the recent FDA approval of the party drug esketamine for the treatment of depression.

Researchers find that valproate decreases brain volume in a region associated with emotion processing across all participants.

New research suggests that clinicians should exercise caution prescribing SNRIs as first-line treatment for mood and anxiety disorders.